Compartment-specific Zinc Misallocation in Diabetic Foot Ulcers: Mechanistic Coupling Between Macrophage M1 Locking and MMP-9 Hyperactivation.

Diabetic foot ulcer (DFU) remains a formidable clinical challenge characterized by a persistent failure of the regenerative process. Affecting approximately 15-25% of diabetic individuals over their lifetime, DFU is associated with a disproportionate risk of lower-limb amputation and mortality. Although zinc is a fundamental requirement for cutaneous repair, conventional supplementation strategies often yield inconsistent therapeutic outcomes. This review addresses this clinical gap by introducing the Zinc Misallocation Hypothesis, which posits that compartment-specific collapse of ionic partitioning represents a mechanistically distinct contributor to DFU chronicity, independent of total zinc deficiency. Under conditions of chronic hyperglycemia and oxidative stress, a pathological spatiotemporal decoupling occurs, leading to functional intracellular Zn²⁺ scarcity alongside a destructive accumulation of labile Zn²⁺ in the extracellular matrix. This ionic misallocation establishes a dual-track inhibitory mechanism that may contribute to sustained repair impairment. Intracellularly, functional Zn²⁺ depletion disrupts the structural integrity of zinc-finger regulatory proteins such as A20 and CYLD, leading to the sustained disinhibition of the NF-κB signaling axis. This biochemical locking prevents the transition of macrophages from a pro-inflammatory M1 state to a pro-reparative M2 phenotype. Simultaneously, the pathological saturation of Zn²⁺ in the extracellular environment facilitates the hyperactivation of matrix metalloproteinases, specifically MMP-9, while concurrently inactivating endogenous inhibitors such as TIMP-1. The markedly elevated proteolytic activity triggers extensive degradation of the basement membrane and induces a state of multi-lineage cellular arrest, where the migratory and proliferative capacity of keratinocytes, fibroblasts, and endothelial cells is substantially attenuated. To resolve this biochemical stalemate, we propose a reciprocal regulatory paradigm utilizing advanced responsive delivery systems, such as ROS-sensitive nanocarriers and metal-organic frameworks. These precision platforms facilitate a dual-action operation designed to sequester pathogenic extracellular zinc while selectively replenishing functional intracellular pools. Ultimately, the restoration of compartment-specific zinc homeostasis represents a rational therapeutic objective for attenuating the self-reinforcing pathological state of the chronic diabetic wound.